An ideal therapeutic anti-SARS-CoV-2 antibody would resist viral escape 1 , 2 – 3 , have
activity against diverse sarbecoviruses 4 , 5 , 6 – 7 , and be highly protective through viral …

Efficient therapeutic options are needed to control the spread of severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) that has caused more than 922,000 fatalities as of 13 …

SARS-CoV-2 infection—which involves both cell attachment and membrane fusion—relies
on the angiotensin-converting enzyme 2 (ACE2) receptor, which is paradoxically found at low …

SARS-CoV-2 can mutate and evade immunity, with consequences for efficacy of emerging
vaccines and antibody therapeutics. Here, we demonstrate that the immunodominant SARS-…

Rapidly evolving influenza A viruses (IAVs) and influenza B viruses (IBVs) are major causes
of recurrent lower respiratory tract infections. Current influenza vaccines elicit antibodies …

SARS-CoV-2 can mutate to evade immunity, with consequences for the efficacy of emerging
vaccines and antibody therapeutics. Herein we demonstrate that the immunodominant …

Heteromeric amino acid transporters (HATs) are the unique example, known in all kingdoms
of life, of solute transporters composed of two subunits linked by a conserved disulfide …

Ergothioneine is a sulfur metabolite that occurs in microorganisms, fungi, plants, and animals.
The physiological function of ergothioneine is not clear. In recent years broad scientific …

Patients on dialysis are at risk of severe course of SARS-CoV-2 infection. Understanding the
neutralizing activity and coverage of SARS-CoV-2 variants of vaccine-elicited antibodies is …

Sulfoxide synthases are nonheme iron enzymes that catalyze oxidative carbon–sulfur bond
formation between cysteine derivatives and N-α-trimethylhistidine as a key step in the …